BioSpace News Archive

Roche Purchases Shares In Tender Offer For InterMune, Inc.

September 29, 2014
·
4 min read
Janssen-Cilag International NV Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat

September 29, 2014
·
6 min read
Drug Development

CytRx Corporation Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer

September 29, 2014
·
7 min read
Drug Development

Keryx Biopharmaceuticals Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease

September 29, 2014
·
8 min read
Drug Development

Bionomics Limited Presents BNC105 Phase 2 Renal Cancer Trial Biomarker Data

September 29, 2014
·
5 min read
Drug Development

Agile Therapeutics, Inc. Announces Dosing Of First Patients In Twirla® Phase 3 SECURE Study

September 29, 2014
·
4 min read
Drug Development

Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C

September 29, 2014
·
10 min read
Drug Development

Janssen Pharmaceutical Inc. Release: ZYTIGA®* Plus Prednisone Demonstrates Statistically Significant Overall Survival In Men With Advanced Prostate Cancer Prior To Chemotherapy

September 29, 2014
·
5 min read
Biomedic Acetaminophen With Codeine: Recall Due To Missing Child-Resistant Packaging

September 29, 2014
·
1 min read
Drug Development

Boehringer Ingelheim Corporation’s Afatinib Meets Primary Endpoint In Phase 3 Study Of Head And Neck Cancer

September 29, 2014
·
13 min read